The Health Resources and Services Administration should increase its oversight of private nonprofit hospitals that participate in the 340B drug savings program to ensure they meet eligibility requirements, the Government Accountability Office said in a report released today. Specifically, GAO said HRSA should ensure that it uses reliable information to verify nonprofit status for all nongovernmental hospitals in the program, verify that each of these hospitals has a contract with a state or local government as required, and verify that the contract was in effect prior to the beginning of the audit review period. GAO also recommended that HRSA revise its contract audit procedures and provide auditors with more specific guidance on how to determine whether the contracts require the hospitals to serve low-income individuals not eligible for Medicaid or Medicare. In comments in the report, the Department of Health and Human Services concurred with all of the recommendations except the one to verify that all nongovernmental hospitals have the required contract with a state or local government.
 
AHA Executive Vice President Tom Nickels said, “We look forward to reviewing this report closely. Most important is that tax-exempt hospitals are accountable to the government and their communities in a variety of important ways. For example, they publicly report annually the benefits they provide. In the most recent year for which comprehensive data is available, 340B tax-exempt hospitals provided more than $56 billion in total benefits to their communities.”

Related News Articles

Headline
The Department of Health and Human Services Feb. 5 in a court filing said it would scrap its current 340B Rebate Model Pilot Program and potentially restart…
Headline
A new AHA blog published Feb. 3 discusses how the 340B Drug Pricing Program serves as an effective solution to some of the nation’s most persistent and…
Blog
Public
Many Americans may be unaware that the services they rely on every day through their local hospital are supported by a program called the 340B Drug Pricing…
Headline
The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and Company policy from taking effect…
Headline
The federal government has dropped its appeal of a preliminary injunction blocking implementation of the Department of Health and Human Services’ 340B Rebate…
Headline
The 1st U.S. Circuit Court of Appeals Jan. 7 denied the government’s motion for a stay in a lawsuit filed by the AHA, the Maine Hospital Association and four…